The genetics of the polycystic ovary syndrome

Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):103-11. doi: 10.1038/ncpendmet0400.

Abstract

Polycystic ovary syndrome (PCOS) is a very common endocrine disorder that has a strong genetic component and is characterized by polycystic ovaries, hyperandrogenemia, and menstrual irregularity. During the past decade, the roles of more than 70 candidate genes have been evaluated for a causal role in PCOS; however, because of genetic and phenotypic heterogeneity and underpowered studies, the results of many of these studies remain inconclusive. Here, the results of the genetic analysis of several candidate genes and gene regions-CYP11A (encoding cytochrome P450, family 11, subfamily A polypeptides), CAPN10 (encoding calpain 10), the insulin gene VNTR (variable number of tandem repeats), and D19S884 (a dinucleotide repeat marker mapping to chromosome 19p13.2)-are discussed in detail. Although past genetic studies of PCOS have yielded only modest results, resources and techniques have been assembled to remedy the major deficits of these early studies, promising that the next few years will be a very exciting and rewarding era for the genetic analysis of PCOS.

Publication types

  • Review

MeSH terms

  • Calpain / genetics*
  • Cholesterol Side-Chain Cleavage Enzyme / genetics*
  • Chromosomes, Human, Pair 19 / genetics*
  • Dinucleotide Repeats / genetics
  • Female
  • Genetic Predisposition to Disease / genetics*
  • Humans
  • Insulin / genetics*
  • Minisatellite Repeats / genetics
  • Pedigree
  • Polycystic Ovary Syndrome / genetics*

Substances

  • Insulin
  • Cholesterol Side-Chain Cleavage Enzyme
  • Calpain
  • calpain 10